Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yohei Asano

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Anticancer Research|April 28, 2025
Recombinant Methioninase and Cisplatinum Act Synergistically to Inhibit Lewis Lung Carcinoma Cells But Not Normal FibroblastsYohei Asano, Qinghong Han, Kohei Mizuta, et al.
BMC Musculoskeletal Disorders|December 11, 2020
Low-grade myofibroblastic sarcoma of the levator scapulae muscle: a case report and literature reviewHirotaka Yonezawa, Norio Yamamoto, Katsuhiro Hayashi, et al.
Cancer Diagnosis & Prognosis|May 5, 2025
Perspective on an Innovative Curative Strategy for Peritoneal Metastasis Involving Peritonectomy, Hyperthermic Intraperitoneal Chemotherapy, and Adjuvant Chemotherapy Identified as Effective in the Histoculture Drug Response Assay (HDRA)Yohei Asano, Yutaka Yonemura, Chihiro Hozumi, et al.
Anticancer Research|October 28, 2025
Very Rapid Eradication of a Large Squamous-Cell Carcinoma of the Head and Neck Treated With First-line Combination Chemotherapy, a Low-methionine Diet, and Oral Recombinant MethioninaseYohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research|November 29, 2025
Selective Synergy of the Combination of Recombinant Methioninase With Cisplatinum and Ivermectin Which Eradicates Lung-Cancer Cells but Has No Synergy and Limited Effect on Normal FibroblastsYohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research|October 28, 2025
Triple Combination of Recombinant Methioninase and the Anti-parasitic Drugs Ivermectin, and Chloroquine Selectively Eradicates Pancreatic Cancer Cells While Sparing Normal FibroblastsYohei Asano, Qinghong Han, Shukuan Li, et al.
In Vivo (Athens, Greece)|February 27, 2026
Ultra-low Concentrations of Cisplatinum Down to the IC<sub>10</sub> in Combination With Recombinant Methioninase Are Synergistically Effective Against Lung Cancer Cells <i>In Vitro</i> and <i>In Vivo</i>Yohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research|June 27, 2025
The Combination of the Autophagy Inhibitor Chloroquine and Recombinant Methioninase Has Selective Synergistic Efficacy on Human Colon Cancer Cells But Not on Normal Human FibroblastsYohei Asano, Qinghong Han, Shukuan Li, et al.
In Vivo (Athens, Greece)|June 30, 2026
Synergy of a Low-methionine Diet and Reduced-dose Cisplatinum Eradicates Experimental Lung-cancer Bone Metastases in a Nude-mouse ModelYohei Asano, Kohei Mizuta, Yuta Miyashi, et al.
Oncology Letters|May 8, 2023
A validation study for the utility of serum microRNA as a diagnostic and prognostic marker in patients with osteosarcomaYoshihiro Araki, Naofumi Asano, Norio Yamamoto, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Anticancer Research|April 28, 2025
Recombinant Methioninase and Cisplatinum Act Synergistically to Inhibit Lewis Lung Carcinoma Cells But Not Normal FibroblastsYohei Asano, Qinghong Han, Kohei Mizuta, et al.
BMC Musculoskeletal Disorders|December 11, 2020
Low-grade myofibroblastic sarcoma of the levator scapulae muscle: a case report and literature reviewHirotaka Yonezawa, Norio Yamamoto, Katsuhiro Hayashi, et al.
Cancer Diagnosis & Prognosis|May 5, 2025
Perspective on an Innovative Curative Strategy for Peritoneal Metastasis Involving Peritonectomy, Hyperthermic Intraperitoneal Chemotherapy, and Adjuvant Chemotherapy Identified as Effective in the Histoculture Drug Response Assay (HDRA)Yohei Asano, Yutaka Yonemura, Chihiro Hozumi, et al.
Anticancer Research|October 28, 2025
Very Rapid Eradication of a Large Squamous-Cell Carcinoma of the Head and Neck Treated With First-line Combination Chemotherapy, a Low-methionine Diet, and Oral Recombinant MethioninaseYohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research|November 29, 2025
Selective Synergy of the Combination of Recombinant Methioninase With Cisplatinum and Ivermectin Which Eradicates Lung-Cancer Cells but Has No Synergy and Limited Effect on Normal FibroblastsYohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research|October 28, 2025
Triple Combination of Recombinant Methioninase and the Anti-parasitic Drugs Ivermectin, and Chloroquine Selectively Eradicates Pancreatic Cancer Cells While Sparing Normal FibroblastsYohei Asano, Qinghong Han, Shukuan Li, et al.
In Vivo (Athens, Greece)|February 27, 2026
Ultra-low Concentrations of Cisplatinum Down to the IC<sub>10</sub> in Combination With Recombinant Methioninase Are Synergistically Effective Against Lung Cancer Cells <i>In Vitro</i> and <i>In Vivo</i>Yohei Asano, Qinghong Han, Shukuan Li, et al.
Anticancer Research|June 27, 2025
The Combination of the Autophagy Inhibitor Chloroquine and Recombinant Methioninase Has Selective Synergistic Efficacy on Human Colon Cancer Cells But Not on Normal Human FibroblastsYohei Asano, Qinghong Han, Shukuan Li, et al.
In Vivo (Athens, Greece)|June 30, 2026
Synergy of a Low-methionine Diet and Reduced-dose Cisplatinum Eradicates Experimental Lung-cancer Bone Metastases in a Nude-mouse ModelYohei Asano, Kohei Mizuta, Yuta Miyashi, et al.
Oncology Letters|May 8, 2023
A validation study for the utility of serum microRNA as a diagnostic and prognostic marker in patients with osteosarcomaYoshihiro Araki, Naofumi Asano, Norio Yamamoto, et al.
Pageof 9